{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:41:40Z","timestamp":1792615300977,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM145497"],"award-info":[{"award-number":["P30GM145497"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103643"],"award-info":[{"award-number":["P20GM103643"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020418","name":"Centralized Otolaryngology Research Efforts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS130249"],"award-info":[{"award-number":["R21NS130249"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jpain.2026.106369","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:28:32Z","timestamp":1783639712000},"page":"106369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical and non-clinical formulations of paclitaxel produce qualitatively and quantitatively different peripheral neuropathy in rats and mice"],"prefix":"10.1016","volume":"48","author":[{"given":"Denise","family":"Giuvelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0570-0041","authenticated-orcid":false,"given":"Deborah","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Houseknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7671-8690","authenticated-orcid":false,"given":"Kerry L.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jpain.2026.106369_bib1","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/ja00738a045","article-title":"Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia","volume":"93","author":"Wani","year":"1971","journal-title":"J Am Chem Soc"},{"issue":"5","key":"10.1016\/j.jpain.2026.106369_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1098-1128(199809)18:5<315::AID-MED3>3.0.CO;2-W","article-title":"Paclitaxel (Taxol): a success story with valuable lessons for natural product drug discovery and development","volume":"18","author":"Cragg","year":"1998","journal-title":"Med Res Rev"},{"issue":"12","key":"10.1016\/j.jpain.2026.106369_bib3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"issue":"1-2","key":"10.1016\/j.jpain.2026.106369_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pain.2004.01.021","article-title":"Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients","volume":"109","author":"Dougherty","year":"2004","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1005805907311","article-title":"Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing","volume":"35","author":"Forsyth","year":"1997","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.jpain.2026.106369_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mus.21874","article-title":"Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy","volume":"43","author":"Park","year":"2011","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11060-007-9438-8","article-title":"Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings","volume":"86","author":"Augusto","year":"2008","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.jpain.2026.106369_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00280-012-2047-z","article-title":"Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine","volume":"71","author":"Boyette-Davis","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"10.1016\/j.jpain.2026.106369_bib9","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/(SICI)1097-4598(199706)20:6<750::AID-MUS15>3.0.CO;2-Y","article-title":"Progression of paclitaxel-induced neuropathy following discontinuation of treatment","volume":"20","author":"van den Bent","year":"1997","journal-title":"Muscle Nerve"},{"issue":"4 3","key":"10.1016\/j.jpain.2026.106369_bib10","first-page":"1","article-title":"Clinical toxicities encountered with paclitaxel (Taxol)","volume":"20","author":"Rowinsky","year":"1993","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.jpain.2026.106369_bib11","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jamaoncol.2018.6771","article-title":"Chemotherapy-Induced Peripheral Neuropathy","volume":"5","author":"Brown","year":"2019","journal-title":"JAMA Oncol"},{"issue":"28","key":"10.1016\/j.jpain.2026.106369_bib12","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.jpain.2026.106369_bib13","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jpain.2026.106369_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/SPC.0000000000000204","article-title":"Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics","volume":"10","author":"Hopkins","year":"2016","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jpain.2026.106369_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113121","article-title":"Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems","volume":"324","author":"Staff","year":"2020","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.jpain.2026.106369_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0306-4522(01)00425-0","article-title":"Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat","volume":"108","author":"Dina","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2026.106369_bib17","article-title":"Alleviation of paclitaxel-induced mechanical hypersensitivity and hyperalgesic priming with AMPK activators in male and female mice","volume":"6","author":"Inyang","year":"2019","journal-title":"Neurobiol Pain"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0023677215575863","article-title":"Gender differences in a mouse model of chemotherapy-induced neuropathic pain","volume":"50","author":"Naji-Esfahani","year":"2016","journal-title":"Lab Anim"},{"issue":"21","key":"10.1016\/j.jpain.2026.106369_bib19","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.lfs.2004.01.002","article-title":"Paclitaxel-induced neuropathic hypersensitivity in mice: responses in 10 inbred mouse strains","volume":"74","author":"Smith","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.jpain.2026.106369_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8217613","article-title":"Evoked and ongoing pain-like behaviours in a rat model of paclitaxel-induced peripheral neuropathy","volume":"2018","author":"Griffiths","year":"2018","journal-title":"Pain Res Manag"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/FBP.0000000000000497","article-title":"Effect of hyperbaric oxygen on chemotherapy-induced neuropathy in male and female rats","volume":"31","author":"Brewer","year":"2020","journal-title":"Behav Pharmacol"},{"issue":"4","key":"10.1016\/j.jpain.2026.106369_bib22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/j.pain.0000000000001798","article-title":"Marked sexual dimorphism in neuroendocrine mechanisms for the exacerbation of paclitaxel-induced painful peripheral neuropathy by stress","volume":"161","author":"Ferrari","year":"2020","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4097\/kjae.2012.62.1.66","article-title":"Gender differences in paclitaxel-induced neuropathic pain behavior and analgesic response in rats","volume":"62","author":"Hwang","year":"2012","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.jpain.2026.106369_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/FBP.0000000000000378","article-title":"Lack of paclitaxel effects on intracranial self-stimulation in male and female rats: comparison to mechanical sensitivity","volume":"29","author":"Legakis","year":"2018","journal-title":"Behav Pharmacol"},{"issue":"3","key":"10.1016\/j.jpain.2026.106369_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0304-3959(01)00363-3","article-title":"A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel","volume":"94","author":"Polomano","year":"2001","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010069","article-title":"A fenofibrate diet prevents paclitaxel-induced peripheral neuropathy in mice","volume":"13","author":"Caillaud","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1-2","key":"10.1016\/j.jpain.2026.106369_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/md18010012","article-title":"RgIA4 accelerates recovery from paclitaxel-induced neuropathic pain in rats","volume":"18","author":"Huynh","year":"2019","journal-title":"Mar Drugs"},{"key":"10.1016\/j.jpain.2026.106369_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fphar.2019.00745","article-title":"Resolvin D5 inhibits neuropathic and inflammatory pain in male but not female mice: distinct actions of D-series resolvins in chemotherapy-induced peripheral neuropathy","volume":"10","author":"Luo","year":"2019","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jpain.2026.106369_bib30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jpain.2018.11.003","article-title":"Monoclonal antibody targeting the matrix metalloproteinase 9 prevents and reverses paclitaxel-induced peripheral neuropathy in mice","volume":"20","author":"Tonello","year":"2019","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2026.106369_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jpain.2026.106369_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"2","key":"10.1016\/j.jpain.2026.106369_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0006-8993(00)02910-3","article-title":"Description of a short-term Taxol-induced nociceptive neuropathy in rats","volume":"887","author":"Authier","year":"2000","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/exnr.1995.1008","article-title":"Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol","volume":"133","author":"Cavaletti","year":"1995","journal-title":"Exp Neurol"},{"issue":"5","key":"10.1016\/j.jpain.2026.106369_bib36","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/j.pain.0000000000001160","article-title":"Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy","volume":"159","author":"Singhmar","year":"2018","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.jpain.2026.106369_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14829","article-title":"Sex differences in PD-L1-induced analgesia in paclitaxel-induced peripheral neuropathy mice depend on TRPV1-based inhibition of CGRP","volume":"30","author":"Cao","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jpain.2026.106369_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577878","article-title":"Ovariectomy increases paclitaxel-induced mechanical hypersensitivity and reduces anti-inflammatory CD4+ T cells in the dorsal root ganglion of female mice","volume":"367","author":"Goode","year":"2022","journal-title":"J Neuroimmunol"},{"issue":"8","key":"10.1016\/j.jpain.2026.106369_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084277","article-title":"Paclitaxel-associated mechanical sensitivity and neuroinflammation are sex-, time-, and site-specific and prevented through cannabigerol administration in C57Bl\/6 mice","volume":"25","author":"Li","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.117.246215","article-title":"Repeated morphine produces sensitization to reward and tolerance to antiallodynia in male and female rats with chemotherapy-induced neuropathy","volume":"365","author":"Legakis","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2026.106369_bib41","series-title":"Services USDoHaH, ed","article-title":"Guidance for industry: estimating the maximum safe starting dose in initial clincial trials for therapeutics in adult healthy volunteers","author":"Administration FaD","year":"2005"},{"issue":"16","key":"10.1016\/j.jpain.2026.106369_bib42","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0707056","article-title":"Weekly paclitaxel in the adjuvant treatment of breast cancer","volume":"358","author":"Sparano","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2026.106369_bib43","first-page":"165","article-title":"Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans","volume":"10","author":"Li","year":"2018","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.jpain.2026.106369_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1486686","article-title":"Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy","volume":"15","author":"Girdenyte","year":"2024","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jpain.2026.106369_bib45","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/j.pain.0000000000000862","article-title":"Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats","volume":"158","author":"Hamity","year":"2017","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jpain.2026.106369_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/dmd.110.035394","article-title":"Influence of Cremophor EL and genetic polymorphisms on the pharmacokinetics of paclitaxel and its metabolites using a mechanism-based model","volume":"39","author":"Fransson","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.jpain.2026.106369_bib47","first-page":"1454","article-title":"Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications","volume":"59","author":"Sparreboom","year":"1999","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.jpain.2026.106369_bib48","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1021\/acschemneuro.8b00703","article-title":"Polyester nanoparticle encapsulation mitigates paclitaxel-induced peripheral neuropathy","volume":"10","author":"Ganugula","year":"2019","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"10.1016\/j.jpain.2026.106369_bib49","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jns.12440","article-title":"Impact of drug formulations on kinetics and toxicity in a preclinical model of paclitaxel-induced neuropathy","volume":"26","author":"Klein","year":"2021","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jpain.2026.106369_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/IJN.S372961","article-title":"Paclitaxel has a reduced toxicity profile in healthy rats after polymeric micellar nanoparticle delivery","volume":"18","author":"Lu","year":"2023","journal-title":"Int J Nanomed"},{"issue":"2","key":"10.1016\/j.jpain.2026.106369_bib51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1254\/jphs.11062SC","article-title":"Comparison of peripheral neuropathy induced by standard and nanoparticle albumin-bound paclitaxel in rats","volume":"117","author":"Yamashita","year":"2011","journal-title":"J Pharmacol Sci"},{"issue":"10","key":"10.1016\/j.jpain.2026.106369_bib52","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1007\/s12325-019-01058-6","article-title":"Pharmacokinetics of total and unbound paclitaxel after administration of paclitaxel micellar or nab-paclitaxel: an open, randomized, cross-over, explorative study in breast cancer patients","volume":"36","author":"Borga","year":"2019","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.jpain.2026.106369_bib53","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12885-021-07831-7","article-title":"Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.jpain.2026.106369_bib54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2019.11.034","article-title":"A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel","volume":"156","author":"Vergote","year":"2020","journal-title":"Gynecol Oncol"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590026001872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590026001872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:53:44Z","timestamp":1792612424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590026001872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":54,"alternative-id":["S1526590026001872"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2026.106369","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and non-clinical formulations of paclitaxel produce qualitatively and quantitatively different peripheral neuropathy in rats and mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2026.106369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}],"article-number":"106369"}}